"Cholinergic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
| Descriptor ID |
D018680
|
| MeSH Number(s) |
D27.505.519.625.120.200 D27.505.696.577.120.200
|
| Concept/Terms |
Cholinergic Antagonists- Cholinergic Antagonists
- Antagonists, Cholinergic
- Cholinergic Antagonist
- Antagonist, Cholinergic
- Cholinergic-Blocking Agents
- Agents, Cholinergic-Blocking
- Cholinergic Blocking Agents
- Cholinolytics
- Acetylcholine Antagonists
- Antagonists, Acetylcholine
- Cholinergic Receptor Antagonists
- Antagonists, Cholinergic Receptor
- Receptor Antagonists, Cholinergic
Anticholinergic Agents- Anticholinergic Agents
- Agents, Anticholinergic
- Anticholinergics
- Anti-Cholinergics
- Anti Cholinergics
|
Below are MeSH descriptors whose meaning is more general than "Cholinergic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Cholinergic Antagonists".
This graph shows the total number of publications written about "Cholinergic Antagonists" by people in this website by year, and whether "Cholinergic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2011 | 2 | 1 | 3 |
| 2013 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholinergic Antagonists" by people in Profiles.
-
Nightingale G, Scopelliti EM, Casten R, Woloshin M, Xiao S, Kelley M, Chang AM, Hollander JE, Leiby BE, Peterson AM, Pizzi LT, Rising KL, White N, Rovner B. Polypharmacy and Potentially Inappropriate Medication Use in Older Blacks with Diabetes Mellitus Presenting to the Emergency Department. J Aging Health. 2022 Aug-Sep; 34(4-5):499-507.
-
Denisenko AA, Clark CB, D'Amico M, Murphy AM. Evaluation and management of female urinary incontinence. Can J Urol. 2021 08; 28(S2):27-32.
-
Rutman MP, Horn JR, Newman DK, Stefanacci RG. Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug?Drug Interactions. Clin Drug Investig. 2021 Apr; 41(4):293-302.
-
Al-Holou SN, Lipsky SN, Wasserman BN. Don't Sweat the Blown Pupil: Anisocoria in Patients Using Qbrexza. Ophthalmology. 2020 10; 127(10):1381.
-
Iyer S, Lozo S, Botros C, Wang C, Warren A, Sand P, Tomezsko J, Botros S, Gafni-Kane A, Sasso K, Goldberg RP. Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study. Int Urogynecol J. 2020 Dec; 31(12):2653-2660.
-
Lodwick D, Asti L, Deans K, Minneci P, McLeod D. Variation in Practice Patterns for the Management of Newborn Spina Bifida in the United States. Urology. 2017 Feb; 100:207-212.
-
Naples JG, Marcum ZA, Perera S, Gray SL, Newman AB, Simonsick EM, Yaffe K, Shorr RI, Hanlon JT. Concordance Between Anticholinergic Burden Scales. J Am Geriatr Soc. 2015 Oct; 63(10):2120-4.
-
Haft S, Farquhar D, Carey R, Mirza N. Anticholinergic Use Is a Major Risk Factor for Dysphonia. Ann Otol Rhinol Laryngol. 2015 Oct; 124(10):797-802.
-
Hersh L, Salzman B. Clinical management of urinary incontinence in women. Am Fam Physician. 2013 May 01; 87(9):634-40.
-
Fast AM, Nees SN, Van Batavia JP, Combs AJ, Glassberg KI. Outcomes of targeted treatment for vesicoureteral reflux in children with nonneurogenic lower urinary tract dysfunction. J Urol. 2013 Sep; 190(3):1028-32.